Patient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19: A protocol of a META-epidemiological study
Digital
- Autores:
-
Jimenez‑Mora, Mario A.
Ramírez-Varela, Andrea
Meneses‑Echavez, Jose F.
Bidonde, Julia
Angarita‑Fonseca, Adriana
Siemieniuk, Reed A. C.
Zeraatkar, Dena
Bartoszko, Jessica J.
Brignardello‑Petersen, Romina
Honarmand, Kimia
Rochwerg, Bram
Guyatt, Gordon
Yepes‑Nuñez, Juan José
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2021
- Institución:
- Universidad de Santander
- Repositorio:
- Repositorio Universidad de Santander
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.udes.edu.co:001/6307
- Acceso en línea:
- https://doi.org/10.1186/s13643-021-01838-8
https://repositorio.udes.edu.co/handle/001/6307
- Palabra clave:
- Patient-important outcome
Reporting
Treatment
Prevention
Coronavirus
Covid-19
- Rights
- openAccess
- License
- © The Author(s) 2021.
| id |
RUDES2_b473ea83bb4fd9a034aacc31f1dcfef8 |
|---|---|
| oai_identifier_str |
oai:repositorio.udes.edu.co:001/6307 |
| network_acronym_str |
RUDES2 |
| network_name_str |
Repositorio Universidad de Santander |
| repository_id_str |
|
| dc.title.spa.fl_str_mv |
Patient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19: A protocol of a META-epidemiological study |
| title |
Patient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19: A protocol of a META-epidemiological study |
| spellingShingle |
Patient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19: A protocol of a META-epidemiological study Patient-important outcome Reporting Treatment Prevention Coronavirus Covid-19 |
| title_short |
Patient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19: A protocol of a META-epidemiological study |
| title_full |
Patient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19: A protocol of a META-epidemiological study |
| title_fullStr |
Patient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19: A protocol of a META-epidemiological study |
| title_full_unstemmed |
Patient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19: A protocol of a META-epidemiological study |
| title_sort |
Patient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19: A protocol of a META-epidemiological study |
| dc.creator.fl_str_mv |
Jimenez‑Mora, Mario A. Ramírez-Varela, Andrea Meneses‑Echavez, Jose F. Bidonde, Julia Angarita‑Fonseca, Adriana Siemieniuk, Reed A. C. Zeraatkar, Dena Bartoszko, Jessica J. Brignardello‑Petersen, Romina Honarmand, Kimia Rochwerg, Bram Guyatt, Gordon Yepes‑Nuñez, Juan José |
| dc.contributor.author.none.fl_str_mv |
Jimenez‑Mora, Mario A. Ramírez-Varela, Andrea Meneses‑Echavez, Jose F. Bidonde, Julia Angarita‑Fonseca, Adriana Siemieniuk, Reed A. C. Zeraatkar, Dena Bartoszko, Jessica J. Brignardello‑Petersen, Romina Honarmand, Kimia Rochwerg, Bram Guyatt, Gordon Yepes‑Nuñez, Juan José |
| dc.contributor.researchgroup.spa.fl_str_mv |
Fisioterapia Integral |
| dc.subject.proposal.eng.fl_str_mv |
Patient-important outcome Reporting Treatment Prevention Coronavirus Covid-19 |
| topic |
Patient-important outcome Reporting Treatment Prevention Coronavirus Covid-19 |
| description |
Digital |
| publishDate |
2021 |
| dc.date.issued.none.fl_str_mv |
2021-11-01 |
| dc.date.accessioned.none.fl_str_mv |
2022-03-10T19:11:12Z |
| dc.date.available.none.fl_str_mv |
2022-03-10T19:11:12Z |
| dc.type.spa.fl_str_mv |
Artículo de revista |
| dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
| dc.type.content.spa.fl_str_mv |
Text |
| dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.redcol.spa.fl_str_mv |
http://purl.org/redcol/resource_type/ART |
| dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| format |
http://purl.org/coar/resource_type/c_6501 |
| status_str |
publishedVersion |
| dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1186/s13643-021-01838-8 |
| dc.identifier.uri.none.fl_str_mv |
https://repositorio.udes.edu.co/handle/001/6307 |
| url |
https://doi.org/10.1186/s13643-021-01838-8 https://repositorio.udes.edu.co/handle/001/6307 |
| dc.language.iso.spa.fl_str_mv |
eng |
| language |
eng |
| dc.relation.citationendpage.spa.fl_str_mv |
6 |
| dc.relation.citationissue.spa.fl_str_mv |
289 |
| dc.relation.citationstartpage.spa.fl_str_mv |
1 |
| dc.relation.citationvolume.spa.fl_str_mv |
10 |
| dc.relation.cites.none.fl_str_mv |
Jimenez-Mora, M.A., Varela, A.R., Meneses-Echavez, J.F. et al. Patient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19: a protocol of a META-epidemiological study. Syst Rev 10, 289 (2021). https://doi.org/10.1186/s13643-021-01838-8 |
| dc.relation.indexed.spa.fl_str_mv |
Scopus |
| dc.relation.ispartofjournal.spa.fl_str_mv |
Systematic Reviews |
| dc.rights.spa.fl_str_mv |
© The Author(s) 2021. |
| dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.creativecommons.spa.fl_str_mv |
Atribución 4.0 Internacional (CC BY 4.0) |
| dc.rights.uri.spa.fl_str_mv |
https://creativecommons.org/licenses/by/4.0/ |
| rights_invalid_str_mv |
© The Author(s) 2021. Atribución 4.0 Internacional (CC BY 4.0) https://creativecommons.org/licenses/by/4.0/ http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.extent.spa.fl_str_mv |
6 p |
| dc.format.mimetype.spa.fl_str_mv |
application/pdf |
| dc.publisher.place.spa.fl_str_mv |
Reino Unido |
| dc.source.spa.fl_str_mv |
https://systematicreviewsjournal.biomedcentral.com/track/pdf/10.1186/s13643-021-01838-8.pdf |
| institution |
Universidad de Santander |
| bitstream.url.fl_str_mv |
https://repositorio.udes.edu.co/bitstreams/471afd17-9bc0-45fe-929a-98d24e445903/download https://repositorio.udes.edu.co/bitstreams/fae600ac-bf0c-4084-979e-97074f659e83/download https://repositorio.udes.edu.co/bitstreams/aa9fe702-e62c-45cf-bc26-4350eedb0d90/download https://repositorio.udes.edu.co/bitstreams/bca29346-724b-4382-8744-19b7c19e7795/download |
| bitstream.checksum.fl_str_mv |
3ee2ad38cf43102d911b93a88a3ee801 38d94cf55aa1bf2dac1a736ac45c881c 5dbe86c1111d64f45ba435df98fdc825 fe78d9ec6bfe39bbc67f841e99155054 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Universidad de Santander |
| repository.mail.fl_str_mv |
soporte@metabiblioteca.com |
| _version_ |
1814158756600086528 |
| spelling |
Jimenez‑Mora, Mario A.4ec29d92-34d1-499f-9c35-3fe745ee4aea-1Ramírez-Varela, Andrea5c7d651f-e71a-4fe3-9c05-c5f4be48ba4c-1Meneses‑Echavez, Jose F.35d83434-41b6-48e9-bf1b-8725de4548b4-1Bidonde, Julia0dc44e2d-fecb-48d0-aaa6-d5e842a27ea7-1Angarita‑Fonseca, Adrianacc09eddd-62ac-4be2-a577-9d029de10bfd-1Siemieniuk, Reed A. C.5db3ffcc-c03c-4e72-862e-5bef44dffc49-1Zeraatkar, Dena21b27023-33e9-4c16-9dc2-c99d1e75ab4a-1Bartoszko, Jessica J.6b9390ba-7b8a-4aab-983d-091d53f429c5-1Brignardello‑Petersen, Romina07bf65bd-1ff8-4228-ba9b-31dc44712ac4-1Honarmand, Kimia522e9dd0-cc86-44af-8c31-a0f589d636ae-1Rochwerg, Bramc5410574-0fa9-4afb-8a8a-669dca2b2313-1Guyatt, Gordon1bbffdcd-09c9-4112-811c-06e84ab54843-1Yepes‑Nuñez, Juan Joséc669a947-f8ec-4230-8016-e84be589e081-1Fisioterapia Integral2022-03-10T19:11:12Z2022-03-10T19:11:12Z2021-11-01DigitalBackground: The coronavirus disease 19 (covid-19) pandemic has underscored the need to expedite clinical research, which may lead investigators to shift away from measuring patient-important outcomes (PIO), limiting research applicability. We aim to investigate if randomized controlled trials (RCTs) of covid-19 pharmacological thera‑ pies include PIOs. Methods: We will perform a meta-epidemiological study of RCTs that included people at risk for, or with suspected, probable, or confrmed covid-19, examining any pharmacological treatment or blood product aimed at prophylaxis or treatment. We will obtain data from all RCTs identifed in a living network metanalysis (NMA). The main data sources are the living WHO covid-19 database up to 1 March 2021 and six additional Chinese databases up to 20 February 2021. Two reviewers independently will review each citation, full-text article, and abstract data. To categorize the out‑ comes according to their importance to patients, we will adapt a previously defned hierarchy: a) mortality, b) quality of life/ functional status/symptoms, c) morbidity, and d) surrogate outcomes. Outcomes within the category a) and b) will be considered critically important to patients, and outcomes within the category c) will be regarded as important. We will use descriptive statistics to assess the proportion of studies that report each category of outcomes. We will perform univariable and multivariable analysis to explore associations between trial characteristics and the likelihood of reporting PIOs. Discussion: The fndings from this meta-epidemiological study will help health care professionals and researchers understand if the current covid-19 trials are efectively assessing and reporting the outcomes that are important to patients. If a defciency in capturing PIOs is identifed, this information may help inform the development of future RCTs in covid-19. Systematic review registrations: Open Science Framework registration: osf.io/6xgjz.Ciencias Médicas y de la Salud6 papplication/pdfhttps://doi.org/10.1186/s13643-021-01838-8https://repositorio.udes.edu.co/handle/001/6307engReino Unido6289110Jimenez-Mora, M.A., Varela, A.R., Meneses-Echavez, J.F. et al. Patient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19: a protocol of a META-epidemiological study. Syst Rev 10, 289 (2021). https://doi.org/10.1186/s13643-021-01838-8ScopusSystematic Reviews© The Author(s) 2021.info:eu-repo/semantics/openAccessAtribución 4.0 Internacional (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/http://purl.org/coar/access_right/c_abf2https://systematicreviewsjournal.biomedcentral.com/track/pdf/10.1186/s13643-021-01838-8.pdfPatient-important outcomeReportingTreatmentPreventionCoronavirusCovid-19Patient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19: A protocol of a META-epidemiological studyArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85Todas las AudienciasPublicationORIGINALPatient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19. A protocol of a META-epidemiological study.pdfPatient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19. A protocol of a META-epidemiological study.pdfapplication/pdf239860https://repositorio.udes.edu.co/bitstreams/471afd17-9bc0-45fe-929a-98d24e445903/download3ee2ad38cf43102d911b93a88a3ee801MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-859https://repositorio.udes.edu.co/bitstreams/fae600ac-bf0c-4084-979e-97074f659e83/download38d94cf55aa1bf2dac1a736ac45c881cMD52TEXTPatient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19. A protocol of a META-epidemiological study.pdf.txtPatient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19. A protocol of a META-epidemiological study.pdf.txtExtracted texttext/plain5https://repositorio.udes.edu.co/bitstreams/aa9fe702-e62c-45cf-bc26-4350eedb0d90/download5dbe86c1111d64f45ba435df98fdc825MD53THUMBNAILPatient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19. A protocol of a META-epidemiological study.pdf.jpgPatient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19. A protocol of a META-epidemiological study.pdf.jpgGenerated Thumbnailimage/jpeg11972https://repositorio.udes.edu.co/bitstreams/bca29346-724b-4382-8744-19b7c19e7795/downloadfe78d9ec6bfe39bbc67f841e99155054MD54001/6307oai:repositorio.udes.edu.co:001/63072023-10-10 12:39:55.756https://creativecommons.org/licenses/by/4.0/© The Author(s) 2021.https://repositorio.udes.edu.coRepositorio Universidad de Santandersoporte@metabiblioteca.comTGljZW5jaWEgZGUgUHVibGljYWNpw7NuIFVERVMKRGlyZWN0cmljZXMgZGUgVVNPIHkgQUNDRVNPCgo= |